Scientists probe hidden danger of low blood sugar in diabetes
NCT ID NCT00678145
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at why people with type 1 diabetes often fail to sense dangerously low blood sugar (hypoglycemia). Researchers tested how opioid drugs like morphine and naloxone affect the body's ability to respond to low sugar. The goal was to better understand the problem, not to find a treatment. The study was terminated early and included 39 healthy volunteers without diabetes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AUTONOMIC FAILURE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Albert Einstein College of Medicine / General Clinical Research Center
The Bronx, New York, 10461, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Quitting smoking may also ward off diabetes — a trial puts the dual strategy to the test
- Could a simple clinic Check-In change catch hidden high blood pressure and diabetes?
- Decades-Long study of 121,700 nurses aims to uncover hidden heart disease triggers
- Could donating blood help control diabetes and fatty liver?
- Phone-Based fitness program aims to cut heart disease in african american women
- Could a wearable sensor replace Finger-Sticks for hospital diabetes care?